Phase II study of single-agent cetuximab in KRAS g13d mutant metastatic colorectal cancer

M. Schirripa, F. Loupakis, S. Lonardi, C. Cremolini, F. Bergamo, V. Zagonel, A. Falcone

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2503
Number of pages1
JournalAnnals of Oncology
Issue number12
Publication statusPublished - Dec 1 2015

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this